TamPub - Selaus tekijän mukaan "Namujju, Proscovia"
Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries Natunen, Kari; Lehtinen, Johannes; Namujju, Proscovia; Sellors, John; Lehtinen, Matti (2011)
Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine - a pilot study Namujju, Proscovia; Pajunen, Emma; Simen-Kapeu, Aline; Hedman, Lea; Merikukka, Marko; Surcei, Heljä-Marja; Kirnbauer, Reinhard; Apter, Dan; Paavonen, Jorma; Hedman, Klaus; Lehtinen, Matti (2014)
articleBackground The AS04-adjuvanted bivalent L1 virus-like-particle (VLP) vaccine (Cervarix™) against infection with human papillomavirus (HPV) types 16/18 holds great promise to prevent HPV16/18 infections and associated ...
The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years Makalembe, Miriam; Banura, Cecily; Namujju, Proscovia; Mirembe, Florence (2014)
articleBackground Data on Human Papilloma virus (HPV) vaccine immune response in sub-Saharan Africa is still sparse yet such knowledge is critical for optimal implementation and monitoring of HPV vaccines. Our primary objective ...